Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer.
Conditions: Breast Cancer Interventions: Drug: Tamoxifen 10 MG; Drug: Exemestane 25 MG Sponsors: Andrea DeCensi; Dana-Farber/Brigham and Women ' s Cancer Center; Herbert Irving Comprehensive Cancer Center; Istituto Europeo di Oncologia; Breast Cancer Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Breast and Cervical Cancer Education Program
Conditions: Cervical Cancer; Breast Cancer; Health Behavior Interventions: Other: Educational Intervention Sponsors: Johns Hopkins University; Older Women Embracing Life; The John G. Bartlett Specialty Practice Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases
Conditions: Breasr Cancer Interventions: Drug: SHR-A1811; Drug: Bevacizumab Sponsors: Huihua Xiong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Breast Cancer Screening in Ghana
Conditions: Breast Cancer Female Interventions: Other: Bundling; Other: MEGH Sponsors: Penn State University; University of Ghana Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Trastuzumab+pyrotinib+taxene Sponsors: Huihua Xiong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer
Conditions: Breast Cancer Interventions: Radiation: Preoperative accelerated partial breast irradiation; Procedure: Breast conserving surgery; Procedure: Sentinel node procedure; Procedure: Biopsy track removal Sponsors: The Netherlands Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Probability of OncotypeDx to Reallocate as Low or High Risk of Recurrence Breast Cancer Patients With Uncertain Biology
Conditions: Breast Cancer Sponsors: Fondazione Sandro Pitigliani; Genomic Health ®, Inc.; Istituto Toscano Tumori Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Aromatase inhibitors or tamoxifen Sponsors: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
Conditions: Breast Cancer Interventions: Behavioral: Survey; Behavioral: mHealth app Sponsors: UNC Lineberger Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)
Conditions: Breast Cancer Interventions: Behavioral: Prehabilitation exercise program Sponsors: Institut Nacional d ' Educacio Fisica de Catalunya; ICFO - The Institute of Photonics Sciences; Hospital Clinic of Barcelona; Institut d ' Investigacions Biom èdiques August Pi i Sunyer; Universidad San Jorge Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging
Conditions: Breast Cancer Interventions: Diagnostic Test: 18F FDG PET/CT; Diagnostic Test: 68Ga DOTATATE PET/CT Sponsors: Celal Bayar University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide
Conditions: Stage IV Breast Cancer Interventions: Combination Product: Karanahan Sponsors: KARANAHAN Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Sacituzumab Govitecan Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population
Conditions: Breast Cancer Sponsors: Ain Shams University; British University In Egypt Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma
Conditions: Invasive Breast Cancer Interventions: Other: no intervention Sponsors: Marwa Mahmoud Hassan; Qena Oncology Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
